CYTO Message Board - Msg: 4973925

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO

CYTO 0.300

+241.1%

Dec 19 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Oravetz who wrote (7312)	6/23/1998 9:23:00 AM
From: Jim Oravetz	Read Replies (1) of 8116

Found this under SI Opening screen, David Zgodzinski - Biotech - Sex and Dying: May 19,1998 ------------------------------------------------------------------------------------------------------- The CYTO thread has been a boulevard of broken dreams, lately. Cytogen's stock has been dead money for months, trading in the $1-$2 range, too close to the ground for comfort. Cytogen's claim to fame is their little compound called Quarament. Unfortunately, it has not been generating the type of excitement that would help the stock. But there might be some reason to hope. Robert M. Winn made this interesting observation to the thread on May 5, the day after the tumultuous Entremed news... "My personal gut feeling is that all cancer stocks will show good revenues over the next couple of years. Given the hope of a magic bullet being available in two to five years, both patients and doctors are going to be more aggressive in cancer treatments in order to survive until a cure is found. The study that showed that Quadrament added just one more year to the life of a breast cancer patient means that Quad is a lot more important if someone is to survive until the cure. "

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next